CMS to issue innovation project awards for QIOs

The Centers for Medicare & Medicaid Services has announced two projects that focus on supporting and scaling quality improvement organizations.

Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) can collaborate with healthcare providers and/or partners to compete for 28 Special Innovation Project (SIP) awards that fall within two topic categories totaling $8 million. Statements of Objectives will be released in early April to the QIO community. Information regarding award dates will be included in the Statement of Objectives.

SIPs are two-year quality improvement projects that align with the goals of the CMS Quality Strategy and emphasize the power of partnerships, according to the agency.

The following are the two SIP categories for QIN-QIOs to consider:

  1. “Innovations that Advance Local Efforts for Better Care and Smarter Spending,” address healthcare quality issues that occur within specific QIN-QIO regions.
  1. “Interventions that are Ripe for Spread and Scalability,” focus on expanding the scope and national impact of a quality improvement project that has experienced proven but limited success. The expectation is that similar benefits would be experienced on a large scale if spread throughout the greater healthcare community.

The scalability category aligns with the CMS Strategic Innovation Engine (SIE), launched in August of 2015, which is working to rapidly move innovative, evidence-based quality practices from research to implementation through the QIO Program.

In consultation with the SIE Executive Leadership Council, CMS is seeking projects that streamline patient flow in various healthcare settings; work with health plans and/or care coordination providers to deploy an integrated approach to post-acute care that results in enhanced care management, safe transitions from one care setting to another, improved health outcomes, and reductions in harms; increase value; address acute pain manaement; and use big data analytics.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.